Manuela Dingeldey
Berlin, BE 13353, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
CD8+ T cell-derived CD40L mediates noncanonical cytotoxicity in CD40-expressing cancer cells.
Journal: Science advances
Published: May 21, 2025
Aging and Viral Evolution Impair Immunity Against Dominant Pan-Coronavirus-Reactive T Cell Epitope.
Journal: European journal of immunology
Published: February 17, 2025
Hybrid immunity-based induction of durable pan-endemic-coronavirus immunity in the elderly.
Journal: Cell reports
Published: October 08, 2024
Primary ChAdOx1 vaccination does not reactivate pre-existing, cross-reactive immunity.
Journal: Frontiers in immunology
Published: September 28, 2022
SARS-CoV-2 mRNA vaccinations fail to elicit humoral and cellular immune responses in patients with multiple sclerosis receiving fingolimod.
Journal: Journal of neurology, neurosurgery, and psychiatry
Published: April 07, 2022
Cutting Edge: Serum but Not Mucosal Antibody Responses Are Associated with Pre-Existing SARS-CoV-2 Spike Cross-Reactive CD4+ T Cells following BNT162b2 Vaccination in the Elderly.
Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: October 28, 2021
Cross-reactive CD4+ T cells enhance SARS-CoV-2 immune responses upon infection and vaccination.
Journal: Science (New York, N.Y.)
Published: September 01, 2021
SARS-CoV-2-reactive T cells in healthy donors and patients with COVID-19.
Journal: Nature
Published: April 09, 2020
Blockade of the costimulatory CD28-B7 family signal axis enables repeated application of AAV8 gene vectors.
Journal: Journal of thrombosis and haemostasis : JTH
Published: July 19, 2019
Showing 1-9 of 9
Last Updated: 09/26/2026